Evolus, Inc.

EOLS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001570562

SEC filings (opens in a new tab)

In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Evolus, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of EOLS: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	118	2	123	+7
Shares	24.0M	16.3K	25.4M	+1.41M (+5.9%)
Value	$266.3M	$183.0K	$294.2M	+$28.1M (+10.6%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Evolus, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to EOLS in Q2 2022
Institution	Shares	Value	% of portfolio
Tri Locum Partners LP	217,767	$2.53M	1.04%
HSBC Holdings PLC	104,708	$1.21M	0.00%
Swiss National Bank	85,300	$989.0K	0.00%
Schonfeld Strategic Advisors LLC	73,689	$855.0K	0.01%
Ikarian Capital, LLC	45,516	$529.0K	0.22%
UBS Asset Management Americas Inc	43,649	$506.3K	0.00%
Jump Financial, LLC	37,510	$435.0K	0.02%
Squarepoint Ops LLC	31,149	$361.0K	0.00%
Tudor Investment Corp Et Al	30,843	$358.0K	0.01%
Principal Financial Group Inc	29,763	$345.0K	0.00%
Bender Robert & Associates	25,070	$291.0K	0.11%
Engineers Gate Manager LP	23,870	$277.0K	0.01%
Victory Capital Management Inc	20,676	$240.0K	0.00%
AdvisorShares Investments LLC	17,030	$198.0K	0.06%
Renaissance Technologies LLC	12,400	$144.0K	0.00%
Private Trust Co NA	11,558	$134.0K	0.02%
Mirae Asset Global Investments Co., Ltd.	10,755	$125.0K	0.00%
PEAK6 Investments LLC	15,441	$112.3K	0.00%
Altshuler Shaham Ltd	2,296	$27.0K	0.00%
Great West Life Assurance Co	1,731	$20.0K	0.00%
Quadrant Capital Group LLC	161	$2.00K	0.00%
Signaturefd, LLC	86	$1.00K	0.00%
Ellevest, Inc.	37	$0	0.00%
Parallel Advisors, LLC	15	$0	0.00%

Sold out (17)

Institutions that held Evolus, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of EOLS in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Stonepine Capital Management, LLC	586,224	$6.58M
Glenview Capital Management, LLC	394,810	$4.43M
Point72 Asset Management, L.P.	309,800	$3.48M
Worth Venture Partners, LLC	201,543	$2.26M
Brandywine Global Investment Management, LLC	104,596	$1.17M
Two Sigma Advisers, LP	37,900	$425.0K
Federated Hermes, Inc.	32,446	$364.0K
Graham Capital Management, L.P.	26,082	$292.0K
Mariner, LLC	25,463	$286.0K
Cetera Advisors LLC	24,795	$278.0K
Walleye Capital LLC	19,738	$221.0K
Marshall Wace, LLP	16,903	$190.0K
Trexquant Investment LP	13,488	$151.0K
ProShare Advisors LLC	11,978	$134.0K
GWM Advisors LLC	10,583	$119.0K
Point72 Hong Kong Ltd	2,343	$26.0K
Rockefeller Capital Management L.P.	1,000	$11.0K

Not filed for Q2 2022 yet (2)

Institutions that held Evolus, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EOLS in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	10,878	$122.0K
Amalgamated Financial Corp.	5,422	$61.0K